Andrew Left: Valeant May See Higher Before It Sees Lower

The transcript discusses a trading strategy involving Valley and Mallinckrodt stocks, highlighting the potential for a turnaround in Valley's business under new leadership. It also addresses perceived unfairness in market practices, particularly in the pharmaceutical sector, and critiques a Senate hearing involving key industry figures.

What was the speaker's main reason for trading Valley's stock?

• Pressure from investors

• A calculated trading strategy

• A sudden drop in stock price

• A change of heart about the company

What was the speaker's outlook on the company's future after Papa's introduction?

• No change in strategy

• Immediate financial success

• A potential turnaround and viable business plan

• Preparing for bankruptcy

How did the speaker position themselves in the market regarding Valley and Mallinckrodt?

• Long on both Valley and Mallinckrodt

• Short on both Valley and Mallinckrodt

• Long on Valley and short on Mallinckrodt

• Short on Valley and long on Mallinckrodt

What was the speaker's opinion on the Senate's treatment of Bill Ackman and Michael Pearson?

• Supportive and understanding

• Unfair and harsh

• Indifferent and neutral

• Fair and justified

According to the speaker, which company was not being discussed enough in the context of overpriced pharmaceuticals?

• Johnson & Johnson

• Pfizer

• Mallinckrodt

• Valley